2025-09-15 – Press Releases – www.prnewswire.com
SINGAPORE and GUANGZHOU, China, Sept. 15, 2025 /PRNewswire/ — Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA)…
